Infectious complications of erythrodermic psoriasis

Green, Michele S.; Prystowsky, Janet H.; Cohen, Steven R.; Cohen, Jennifer L; Lebwohl, Mark

doi:10.1016/s0190-9622(96)90078-x

Cited by 71 publications

(45 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1 It is not uncommon for patients to present with superinfection, typically by normal skin pathogens such as Staphylococcus aureus and Streptococcus species. 15 Such concurrent infections can precipitate or exacerbate erythrodermic psoriasis and pose substantial risk to the patient. It is essential to identify and treat such bacterial pathogens appropriately.…”

Section: Discussionmentioning

confidence: 99%

Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation

Rosenbach

Hsu

Korman

et al. 2010

Journal of the American Academy of Dermatology

Self Cite

151

185

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation

Rosenbach

Hsu

Korman

et al. 2010

Journal of the American Academy of Dermatology

Self Cite

151

185

View full text Add to dashboard Cite

“…In patients with erythrodermic psoriasis, there seems to be a significant risk of staphylococcal septicemia. 63,64 However, while psoriatic patients have similar abnormalities in cutaneous barrier function to patients with atopic dermatitis, they have far fewer cutaneous infections. 65 This finding has been related to a cytokine profile in psoriatic plaques that upregulates anti-bacterial proteins in keratinocytes.…”

Section: Infectionmentioning

confidence: 99%

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

Kimball

Gladman

Gelfand

et al. 2008

Journal of the American Academy of Dermatology

Self Cite

381

321

View full text Add to dashboard Cite

“…Laboratory abnormalities associated with erythroderma include anemia, leukocytosis, eosinphilia, electrolyte abnormalities, low protein, and abnormal liver function tests. High output cardiac failure may complicate the course of erythrodermic psoriasis [20].…”

Section: Erythrodermic Psoriasismentioning

confidence: 99%

Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis

Myers¹,

Opeola²,

Gottlieb

2004

Curr Rheumatol Rep

View full text Add to dashboard Cite

Psoriasis and psoriatic arthritis are chronic inflammatory diseases that significantly affect patients' quality of life. Not only do these diseases impact patients' physical well-being, but also detrimentally affect their life socially and psychologically. There are many different patterns of skin and joint involvement. Understanding the pathogenesis of these diseases has evolved greatly in the past few decades. It is now understood that psoriasis and psoriatic arthritis are T cell mediated disorders. A number of proinflammatory cytokines have been suggested as playing a role in the disease mechanism, such as tumor necrosis factor-alpha and interferon-gamma. Other important factors proposed in the pathogenesis of these diseases include the role of genetics and environmental factors. New immunomodulating therapies, which are being developed as our understanding of the involvement of innate and adaptive immunity advances, will provide patients with safer, more effective, long-term, management options.

show abstract

Infectious complications of erythrodermic psoriasis

Cited by 71 publications

References 23 publications

Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation

Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis

Contact Info

Product

Resources

About